Article
Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 May 2004
Tascou Semi, Sorensen Tine-Kring, Glénat Valérie, Wang Manping, Lakich Mélissa M, Darteil Raphaël, Vigne Emmanuelle, Thuillier Vincent
Abstract excerpt
We have developed a gene switch based on the human transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) and its activation by rosiglitazone. However, ectopic expression of PPARgamma has been demonstrated to convert myogenic cells into adipocyte-like cells and, more generally, may interfere with the physiology of the target tissue. Consequently we modified the DNA-binding specificity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
